Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

siRNA based drug design, quality, delivery and clinical translation.

Nanomedicine : nanotechnology, biology, and medicine·2020

Same author

Efficient nanocarriers of siRNA therapeutics for cancer treatment.

Translational research : the journal of laboratory and clinical medicine·2019

Same author

MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation.

Journal of drug targeting·2019

Same author

Double-targeted polymersomes and liposomes for multiple barrier crossing.

International journal of pharmaceutics·2016

Same author

Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid.

Oncogene·2015

Same author

Hypoxia-targeted siRNA delivery.

Angewandte Chemie (International ed. in English)·2014

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

10 targeting in myocardial infarction.

B A Khaw, V P Torchilin

Methods in Molecular Medicine

|February 15, 2011

Summary

Developing targeted delivery systems for infarcted myocardium is crucial for effective diagnosis and therapy. Such systems enhance treatment specificity and enable new drug applications for heart attack recovery.

Area of Science:

Cardiovascular Medicine
Biomedical Engineering
Pharmacology

Background:

Targeting pharmaceuticals to infarcted myocardium aims for both diagnostic imaging and therapeutic delivery.
Current diagnostic and therapeutic agents lack specificity for compromised myocardial areas.
Existing treatments for infarcted myocardium have limitations in targeting efficiency.

Purpose of the Study:

To highlight the need for a target-specific delivery system for infarcted myocardium.
To emphasize the potential benefits of enhanced specificity in myocardial infarction diagnosis and therapy.
To explore the possibility of using novel pharmaceuticals with targeted delivery systems.

Main Methods:

Review of existing diagnostic and therapeutic agents for infarcted myocardium.

More Related Videos

Acute Myocardial Infarction in Rats

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

Related Experiment Videos

Last Updated: Jun 4, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Acute Myocardial Infarction in Rats

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

Analysis of the specificity limitations of current myocardial infarction treatments.

Conceptualization of a target-specific delivery system for myocardial infarction.

Main Results:

No current reagents offer specific targeting to the infarcted myocardium.
A target-specific delivery system is essential to improve diagnostic and therapeutic efficacy.
Targeted delivery may allow the use of potent drugs otherwise harmful to healthy tissues.

Conclusions:

Development of target-specific delivery systems is critical for advancing myocardial infarction diagnosis and therapy.
Such systems promise to increase treatment efficacy and broaden therapeutic options.
Future research should focus on creating specific delivery mechanisms for infarcted cardiac tissue.